{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T12:39:08Z","timestamp":1782131948828,"version":"3.54.5"},"reference-count":21,"publisher":"Baishideng Publishing Group Inc.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Clin Oncol"],"abstract":"<jats:p>BACKGROUND<\/jats:p>\n                  <jats:p>Colorectal cancer (CRC), encompassing both colon and rectal carcinogenesis, is a major health concern. Metastatic CRC (mCRC) is the third most common cancer and the second leading cause of cancer-related death in United States adults. Despite advances in therapy, the 5-year survival rate remains low at 15%. KRAS  mutations contribute to treatment resistance by altering the tumor microenvironment, necessitating novel therapeutic approaches.<\/jats:p>\n                  <jats:p>AIM<\/jats:p>\n                  <jats:p>To evaluate immunomodulatory and cytotoxic potential of reovirus as an adjuvant therapy in KRAS -mutant-mCRC patients by analyzing gene and cytokine expression.<\/jats:p>\n                  <jats:p>METHODS<\/jats:p>\n                  <jats:p>Five KRAS -mutant mCRC patients were treated with reovirus. Serum samples were collected at five time points over 15 days. Cytokine levels were measured using enzyme-linked immunosorbent assay, and transcriptomic profiling was performed to assess gene expression. Data were analyzed using the 2-\u0394\u0394Ct method, and statistical significance was determined via  two-tailed t -tests (P  &lt; 0.05).<\/jats:p>\n                  <jats:p>RESULTS<\/jats:p>\n                  <jats:p>Out of 271 genes associated with Janus kinase\/signal transducer and activator of transcription, Ras, Wnt, and phosphoinositide 3-kinase- alpha serine\/threonine-protein kinase pathways, 85 showed significant modulation. Additionally, 17 of 25 cytokines were significantly altered. Reovirus induced changes in both gene and cytokine expression, suggesting activation of a complex intracellular signaling network.<\/jats:p>\n                  <jats:p>CONCLUSION<\/jats:p>\n                  <jats:p>Reovirus demonstrates potential as an immunomodulatory and cytotoxic adjuvant in KRAS -mutant mCRC by altering key signaling pathways and cytokine profiles. These findings support further investigation into its potential therapeutic contributions.<\/jats:p>","DOI":"10.5306\/wjco.v17.i2.113428","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T01:09:54Z","timestamp":1770340194000},"source":"Crossref","is-referenced-by-count":1,"title":["Gene and cytokine expression profiles of metastatic colorectal cancer patients post reovirus administration"],"prefix":"10.5306","volume":"17","author":[{"given":"Vivian","family":"Zweig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhashree","family":"Maitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07038-2"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2019.01.005"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9450754"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-19-1117"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms131012153"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1142172"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-12-0157"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-2385"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2926"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3627"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11081076"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-13-0231"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194915"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01221"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2011.00018"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2019.589"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13051016"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58020203"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2018.0087"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020603"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/1423-0127-20-3"}],"container-title":["World Journal of Clinical Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2218-4333\/full\/v17\/i2\/113428.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/2218-4333\/full\/v17\/i2\/113428.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T01:09:56Z","timestamp":1770340196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2218-4333\/full\/v17\/i2\/113428.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":21,"journal-issue":{"issue":"2"},"alternative-id":["113428"],"URL":"https:\/\/doi.org\/10.5306\/wjco.v17.i2.113428","relation":{},"ISSN":["2218-4333"],"issn-type":[{"value":"2218-4333","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,24]]}}}